Randomized Controlled Trial of Lactoferrin for Prevention of Sepsis in Peruvian Neonates Less than 2500 g

Pediatric Infectious Disease Journal

Volumn 34, Issue 6, 2015, Pages 571-576

  Ochoa, Theresa J ^a,b,c   Zegarra, Jaime ^b,d   Cam, Luis ^e   Llanos, Raul ^a   Pezo, Alonso ^a   Cruz, Karen ^a   Zea Vera, Alonso ^a   Cárcamo, Cesar ^b,f   Campos, Miguel ^b   Bellomo, Sicilia ^b,d  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^e HOSPITAL NACIONAL ALBERTO SABOGAL SOLOGUREN   (Peru)

^f HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

Author keywords

bovine; infant; late onset sepsis; newborn; preterm

Indexed keywords

LACTOFERRIN; PLACEBO; ANTIINFECTIVE AGENT; IMMUNOLOGIC FACTOR;

ALLERGIC RHINITIS; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; ECZEMA; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFECTION PREVENTION; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PERU; PERUVIAN; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; VERY LOW BIRTH WEIGHT; VOMITING; SEPSIS; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; DOUBLE-BLIND METHOD; HUMANS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; LACTOFERRIN; PERU; PILOT PROJECTS; PLACEBOS; SEPSIS; TREATMENT OUTCOME;

EID: 84937712281     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000593     Document Type: Article

References (25)

1. Lawn JE, Rudan I, Rubens C, Four million newborn deaths: is the global research agenda evidence-based? Early Hum Dev 2008 84 809 814
2. Thaver D, Zaidi AK, Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 2009 28 1 Suppl S3 S9
3. Jones G, Steketee RW, Black RE, Bellagio Child Survival Study Group How many child deaths can we prevent this year? Lancet 2003 362 65 71
4. Lucas A, Morley R, Cole TJ, A randomised multicentre study of human milk versus formula and later development in preterm infants. Arch Dis Child Fetal Neonatal Ed 1994 70 F141 F146
5. Lucas A, Morley R, Cole TJ, Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ 1998 317 1481 1487
6. Vohr BR, Poindexter BB, Dusick AM, NICHD Neonatal Research Network Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics 2006 118 e115 e123
7. Howie PW, Forsyth JS, Ogston SA, Protective effect of breast feeding against infection. BMJ 1990 300 11 16
8. Walker A, Breast milk as the gold standard for protective nutrients. J Pediatr 2010 156 2 Suppl S3 S7
9. Ballard O, Morrow AL, Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am 2013 60 49 74
10. Brock JH, Lactoferrin-50 years on. Biochem Cell Biol 2012 90 245 251
11. Manzoni P, Rinaldi M, Cattani S, Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009 302 1421 1428
12. Haque KN, Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 2005 6 3 Suppl S45 S49
13. Ochoa TJ, Chea-Woo E, Baiocchi N, Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J Pediatr 2013 162 349 356
14. Ochoa TJ, Pezo A, Cruz K, Clinical studies of lactoferrin in children. Biochem Cell Biol 2012 90 457 467
15. Manzoni P, Meyer M, Stolfi I, Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev 2014 90 Suppl 1) S60 S65
16. Benjamin DK Jr, Stoll BJ, Infection in late preterm infants. Clin Perinatol 2006 33 871 882. abstract x.
17. Kaufman DA, Lactoferrin supplementation to prevent nosocomial infections in preterm infants. JAMA 2009 302 1467 1468
18. Buccigrossi V, de Marco G, Bruzzese E, Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 2007 61 410 414
19. Lönnerdal B, Jiang R, Du X, Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. J Pediatr Gastroenterol Nutr 2011 53 606 614
20. Manzoni P, Mostert M, Stronati M, Lactoferrin for prevention of neonatal infections. Curr Opin Infect Dis 2011 24 177 182
21. Ochoa TJ, Cleary TG, Effect of lactoferrin on enteric pathogens. Biochimie 2009 91 30 34
22. Vogel HJ, Lactoferrin, a bird's eye view. Biochem Cell Biol 2012 90 233 244
23. Berlutti F, Schippa S, Morea C, Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem Cell Biol 2006 84 351 357
24. Baker HM, Baker EN, A structural perspective on lactoferrin function. Biochem Cell Biol 2012 90 320 328
25. Shane AL, Stoll BJ, Neonatal sepsis: progress towards improved outcomes. J Infect 2014 68 Suppl 1) S24 S32